when to stop tirzepatide Rebound Weight Gain After Stopping (Mounjaro or Zepbound) What Happens When People Stop

"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial." Lancet , 402(10402), 613-626

Combating tobacco use in Saudi Arabia: A review of recent initiatives

This article examines how GLP-1 therapies work, the clinical evidence supporting their use, current prescribing criteria within NHS pathways, and essential monitoring considerations for patients with concurrent metabolic and liver conditions

Currently, the efficacy estimand for injectable semaglutide demonstrates greater weight loss compared to the available oral tablet

Glutathione tc ng ln enzyme tyrosinase, nh lm tng tng hp nhng loi melanin sng, gim tng hp melanin ti

A multicenter, randomized, open-label, phase 3 trial (AcceleRET-MTC) has recently begun to compare pralsetinib with cabozantinib or vandetanib in patients without prior multi-kinase inhibitor therapy in RET -mutant MTC (NCT04760288)